NKX6-3 and diffuse large B-cell lymphoma: These results confirmed NKX6-3 overexpression in DLBCL cell line DOHH-2 which together with OCI-LY1 and WILL-1 represent, therefore, appropriate models to analyze upstream factors and downstream effects of NKX6-3 expression in B-cells.